Phase I, open-label, single-center, multiple-dose, dose-escalation clinical study of SUO11248 (Sunitinib) in subjects with high-risk prostate cancer who have elected to undergo radical prostatectomy

Re: Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial

European Urology ◽

10.1016/j.eururo.2018.07.022 ◽

2018 ◽

Vol 74 (5) ◽

pp. 680-681

Author(s):

David D’Andrea ◽

Shahrokh F. Shariat ◽

Francesco Soria

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Open Label ◽

Phase 3 ◽

Cancer Group ◽

Group 12 ◽

Risk Prostate Cancer ◽

Open Label Phase

Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial

European Urology ◽

10.1016/j.eururo.2018.01.012 ◽

2018 ◽

Vol 73 (6) ◽

pp. 870-876 ◽

Cited By ~ 22

Author(s):

Göran M. Ahlgren ◽

Per Flodgren ◽

Teuvo L.J. Tammela ◽

Pirkko Kellokumpu-Lehtinen ◽

Michael Borre ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Open Label ◽

Phase 3 ◽

Cancer Group ◽

Group 12 ◽

Risk Prostate Cancer ◽

Open Label Phase

Long‐term first‐in‐man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high‐risk prostate cancer after radical prostatectomy

The Prostate ◽

10.1002/pros.24267 ◽

2021 ◽

Author(s):

Anne M. A. Tryggestad ◽

Karol Axcrona ◽

Ulrika Axcrona ◽

Iris Bigalke ◽

Bjørn Brennhovd ◽

...

Keyword(s):

Prostate Cancer ◽

Dendritic Cell ◽

High Risk ◽

Radical Prostatectomy ◽

Phase I ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Trimodal treatment for localized high risk prostate cancer A design of a phase II, multi-center, open-label, randomized, parallel-group study to compare the effectiveness and safety of radical prostatectomy, external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT) versus EBRT and ADT for patients with localized high risk prostate cancer.

Principles and Practice of Clinical Research Journal ◽

10.21801/ppcrj.2020.61.2 ◽

2020 ◽

Vol 6 (1) ◽

pp. 3-8

Author(s):

Roberto Paz-Manrique ◽

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

External Beam Radiotherapy ◽

External Beam ◽

Open Label ◽

Parallel Group ◽

Risk Prostate Cancer ◽

Trimodal Treatment

Comparison of the Efficacy of Definitive Radiotherapy and Radical Prostatectomy in High-Risk Prostate Cancer: A Single-Center Experience

Bulletin of Urooncology ◽

10.4274/uob.galenos.2021.2021.2.2 ◽

2021 ◽

Vol 20 (4) ◽

pp. 225-230

Author(s):

Berrin İnanç ◽

Özlem Mermut ◽

Uğur Yücetaş

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Single Center ◽

Definitive Radiotherapy ◽

Single Center Experience ◽

Neoadjuvant Chemotherapy Using Reduced-Dose Docetaxel Followed by Radical Prostatectomy for Patients With Intermediate and High-Risk Prostate Cancer: A Single-Center Study

The Prostate ◽

10.1002/pros.23165 ◽

2016 ◽

Vol 76 (15) ◽

pp. 1345-1352 ◽

Cited By ~ 4

Author(s):

Alexander Nosov ◽

Sergey Reva ◽

Sergey Petrov ◽

Eldar Mamijev ◽

Roman Novikov ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Neoadjuvant Chemotherapy ◽

Single Center ◽

Reduced Dose ◽

Single Center Study ◽

Risk Prostate Cancer ◽

Center Study

390: Durable Cancer Control in High Risk Prostate Cancer Patients Treated with Radical Prostatectomy

The Journal of Urology ◽

10.1016/s0022-5347(18)30643-8 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 130-130

Author(s):

Markus Graefen ◽

Jochen Walz ◽

Andrea Gallina ◽

Felix K.-H. Chun ◽

Alwyn M. Reuther ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Cancer Patients ◽

Cancer Control ◽

820: Adjuvant Weekly Docetaxel for High-Risk Prostate Cancer Patients after Radical Prostatectomy

The Journal of Urology ◽

10.1016/s0022-5347(18)34989-9 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 222-222 ◽

Cited By ~ 2

Author(s):

Adam S. Kibel ◽

Joel Picus ◽

Michael S. Cookson ◽

Bruce Roth ◽

David F. Jarrard ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Cancer Patients ◽

Weekly Docetaxel ◽

Interaction of adjuvant androgen deprivation therapy with patient comorbidity status on overall survival after radical prostatectomy for high-risk prostate cancer

International Journal of Urology ◽

10.1111/iju.12047 ◽

2012 ◽

Vol 20 (8) ◽

pp. 798-805 ◽

Cited By ~ 1

Author(s):

Brian J Linder ◽

Stephen A Boorjian ◽

Eric C Umbreit ◽

Rachel E Carlson ◽

Laureano J Rangel ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

High Risk ◽

Radical Prostatectomy ◽

Androgen Deprivation Therapy ◽

Androgen Deprivation ◽

Risk Prostate Cancer ◽

Comorbidity Status

Predictive factors for short-term biochemical recurrence-free survival after robot-assisted laparoscopic radical prostatectomy in high-risk prostate cancer patients

International Journal of Clinical Oncology ◽

10.1007/s10147-019-01445-7 ◽

2019 ◽

Vol 24 (9) ◽

pp. 1099-1104 ◽

Cited By ~ 3

Author(s):

Mitsugu Kanehira ◽

Ryo Takata ◽

Shuhei Ishii ◽

Akito Ito ◽

Daiki Ikarashi ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Biochemical Recurrence ◽

Recurrence Free Survival ◽

Robot Assisted ◽

Short Term ◽

Free Survival ◽